1. Home
  2. IMXI vs PCRX Comparison

IMXI vs PCRX Comparison

Compare IMXI & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMXI
  • PCRX
  • Stock Information
  • Founded
  • IMXI 1994
  • PCRX 2006
  • Country
  • IMXI United States
  • PCRX United States
  • Employees
  • IMXI N/A
  • PCRX N/A
  • Industry
  • IMXI Retail: Computer Software & Peripheral Equipment
  • PCRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • IMXI Technology
  • PCRX Health Care
  • Exchange
  • IMXI Nasdaq
  • PCRX Nasdaq
  • Market Cap
  • IMXI 619.2M
  • PCRX 604.7M
  • IPO Year
  • IMXI N/A
  • PCRX 2011
  • Fundamental
  • Price
  • IMXI $21.09
  • PCRX $21.88
  • Analyst Decision
  • IMXI Buy
  • PCRX Buy
  • Analyst Count
  • IMXI 6
  • PCRX 10
  • Target Price
  • IMXI $27.50
  • PCRX $27.60
  • AVG Volume (30 Days)
  • IMXI 137.9K
  • PCRX 762.4K
  • Earning Date
  • IMXI 02-25-2025
  • PCRX 02-27-2025
  • Dividend Yield
  • IMXI N/A
  • PCRX N/A
  • EPS Growth
  • IMXI 21.49
  • PCRX N/A
  • EPS
  • IMXI 1.80
  • PCRX N/A
  • Revenue
  • IMXI $665,673,000.00
  • PCRX $694,957,000.00
  • Revenue This Year
  • IMXI $2.65
  • PCRX $4.83
  • Revenue Next Year
  • IMXI $2.82
  • PCRX $2.16
  • P/E Ratio
  • IMXI $11.74
  • PCRX N/A
  • Revenue Growth
  • IMXI 3.79
  • PCRX 4.40
  • 52 Week Low
  • IMXI $16.17
  • PCRX $11.16
  • 52 Week High
  • IMXI $23.28
  • PCRX $34.01
  • Technical
  • Relative Strength Index (RSI)
  • IMXI 56.50
  • PCRX 68.77
  • Support Level
  • IMXI $19.73
  • PCRX $18.18
  • Resistance Level
  • IMXI $20.64
  • PCRX $22.36
  • Average True Range (ATR)
  • IMXI 0.47
  • PCRX 1.04
  • MACD
  • IMXI -0.03
  • PCRX 0.21
  • Stochastic Oscillator
  • IMXI 100.00
  • PCRX 88.54

About IMXI International Money Express Inc.

International Money Express Inc is a processor of money transfer services in the USA to the Latin America and the Caribbean (LAC) corridor. The company offers wire transfer, money order, Foreign exchange, and cash checking services, while the majority of the revenue is derived from wire transfer and money order fees. The firm's business is organized around one reportable segment that provides money remittance services between the U.S. and Canada to Mexico, Guatemala, and other countries in Latin America, Africa, and Asia.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.

Share on Social Networks: